Direct stringency comparison of two macaque models (single‐high vs. repeat‐low) for mucosal HIV transmission using an identical anti‐HIV chemoprophylaxis intervention
- 1 August 2007
- journal article
- research article
- Published by Wiley in Journal of Medical Primatology
- Vol. 36 (4-5) , 238-243
- https://doi.org/10.1111/j.1600-0684.2007.00241.x
Abstract
In our previous work, oral chemoprophylaxis with tenofovir disoproxil fumarate (TDF) provided partial protection in rhesus macaques against repeated low-dose (RL) intrarectal SHIV162p3 exposure. Here, we make a direct comparison of these previous findings with data generated using a single high (SH)-dose challenge strategy. All 5 (100%) control macaques were infected after a SH challenge and only three of five (60%) TDF-treated macaques became infected. The remaining two TDF-treated macaques remained virus-negative and were susceptible to virus infection upon re-challenge in the absence of oral TDF. Thus, two of five (40%) TDF-treated macaques were protected by the pre-exposure chemoprophylaxis regimen. By comparison with the RL challenge system, only one of four (25%) of TDF-treated macaques were protected from infection, whereas four of four (100%) control macaques became infected using RL challenges. Taken together, these findings indicate that the stringency of the RL challenge model for testing antiretroviral interventions is not lower and possibly greater than that of the SH challenge model.Keywords
This publication has 17 references indexed in Scilit:
- Efficient repeated low-dose intravaginal infection with X4 and R5 SHIVs in rhesus macaque: Implications for HIV-1 transmission in humansVirology, 2007
- Repetitive exposures with simian/human immunodeficiency viruses: strategy to study HIV pre‐clinical interventions in non‐human primatesJournal of Medical Primatology, 2006
- Preclinical Assessment of HIV Vaccines and Microbicides by Repeated Low-Dose Virus ChallengesPLoS Medicine, 2005
- Multiple Vaginal Exposures to Low Doses of R5 Simian‐Human Immunodeficiency Virus: Strategy to Study HIV Preclinical Interventions in Nonhuman PrimatesThe Journal of Infectious Diseases, 2005
- A Period of Transient Viremia and Occult Infection Precedes Persistent Viremia and Antiviral Immune Responses during Multiple Low-Dose Intravaginal Simian Immunodeficiency Virus InoculationsJournal of Virology, 2004
- Brief but Efficient: Acute HIV Infection and the Sexual Transmission of HIVThe Journal of Infectious Diseases, 2004
- Repeated Low-Dose Mucosal Simian Immunodeficiency Virus SIVmac239 Challenge Results in the Same Viral and Immunological Kinetics as High-Dose Challenge: a Model for the Evaluation of Vaccine Efficacy in Nonhuman PrimatesJournal of Virology, 2004
- Use of a Small Molecule CCR5 Inhibitor in Macaques to Treat Simian Immunodeficiency Virus Infection or Prevent Simian–Human Immunodeficiency Virus InfectionThe Journal of Experimental Medicine, 2003
- Recent observations on HIV type-1 infection in the genital tract of men and womenAIDS, 2003
- Titration of an SIVmac251 Stock by Vaginal Inoculation of Indian and Chinese Origin Rhesus Macaques: Transmission Efficiency, Viral Loads, and Antibody ResponsesAIDS Research and Human Retroviruses, 2001